Albert Bourla - Dec 31, 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla
Stock symbol
PFE
Transactions as of
Dec 31, 2024
Transactions value $
$531
Form type
4
Date filed
1/3/2025, 09:49 AM
Previous filing
Dec 17, 2024
Next filing
Jan 15, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $531 +20 +0% $26.53 691K Dec 31, 2024 Common Stock 20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.